10.1002/chem.201605269
Chemistry - A European Journal
FULL PAPER
(0.088 g, 71 % yield). Elemental analysis, calc. for C70H99Au2F6NO4P2S2
(27) (%): C, 50.88; H, 6.04; N, 0.85; S, 3.88. Found: C, 50.86; H, 6.10; N,
0.89; 3.62. 1H NMR (300 MHz, CDCl3): δ (ppm) = 7.75-7.63 (m, 2 H;
ArH); 7.62-7.46 (m, 4 H; ArH), 7.20-7.10 (m, 2 H; ArH), 7.07-6.95 (s, 4 H;
ArH), 2.90 (sept, 2 H; i-PrCH), 2.24 (sept, 4 H; i-PrCH), 2.06 (m, 4 H;
CyCH), 1.95-1.60 (m, 20 H; CyCH2), 1.47 (s, 1 H; Au2µ-C≡CH), 1.45-1.10
(m, 20 H; CyCH2), 1.32 (d, 12 H; i-PrCH3), 1.22 (d, 12 H; i-PrCH3), 0.93
(d, 12 H; i-PrCH3) (see Fig. S44). 31P NMR (CDCl3): δ (ppm) = 38.74 (s,
phosphine ligands) (see Fig. S45). 19F NMR (CDCl3): δ (ppm) = - 78.58 (s,
counter ion Fluor’s) (see Fig. S46). ESI-MS (+MS) m/z: 1371.87 amu for
Langmuir 2000, 16, 2062-2067; c) G. M. Everett, L. E. Blockus, I. M.
Shepperd, Science (Washington, DC, U. S.) 1956, 124, 79.
[2]
a) L. C. S. L. Morais, L. J. Quintans-Junior, C. I. F. Franco, J. R. G. S.
Almeida, R. N. Almeida, Pharmacol., Biochem. Behav. 2004, 79, 745-
749; b) H. Szmigielska, A. Szmigielski, A. Szadowska, Pol. J.
Pharmacol. 1993, 45, 291-298; c) V. Dutt Sharma, M. A. Ilies, Med. Res.
Rev. 2014, 34, 1-44.
[3]
[4]
[5]
a) J. N. Wilson, S. M. Waybright, K. McAlpine, U. H. F. Bunz,
Macromolecules 2002, 35, 3799-3800; b) C.-J. Li, W. T. I. V. Slaven,
C.-J. Li, Y.-P. Chen, V. T. John, S. H. Rachakonda, Chem. Commun.
(Cambridge) 1998, 1351-1352.
- +
[C70H99Au2F6NO4P2S2 (27) - N(SO2CF3)2 ] (see Fig. S47). ESI-MS (-MS)
m/z: 279.76 amu for anionic counter ion [N(SO2CF3)2]- of complex 27
(see Fig. S47).
a) C. R. Gillett, O. S. Hellwig, ACETYLENE-GAS GENERATOR 1898,
US603506A, CAPLUS AN 1906:71268(Patent); b) A. Rosenberg,
APPARATUS FOR THE GENERATION OF ACETYLENE GAS 1906,
US824509A, CAPLUS AN 1906:52518(Patent).
Isolation of cationic [(σ,π)](L1-Au)2(µ-I)[SbF6] complex 31: A mixture
of complex [Au(L1)(CH3CN)][SbF6] (1) (0.116 g, 0.15 mmol) and 1-iodo-
2-(trimethylsilyl)acetylene (0.10 g, 0.45 mmol) was dissolved in
dichloromethane (2 ml). The solution was stirred at 40 ºC under argon
atmosphere. The stirring was maintained for 48 h. Then, the resulting
orange mixture was diluted with other 2 ml of CH2Cl2, filtered and the
supernatant was covered carefully with a layer of 1.5 ml of n-hexane. A
colourless crystalline material suitable for X-ray crystallography
corresponding to complex 31 was formed upon standing for 30 h at -30
ºC. The solid was collected by filtration, washed with cold n-hexane and
dried under vacuum (0.093 g, 92 % yield). Elemental analysis, calc. for
C40H54Au2F6IP2Sb (31) (%): C, 35.50; H, 4.02. Found: C, 35.47; H, 4.27.
1H NMR (300 MHz, CD2Cl2): δ (ppm) = 7.90-7.78 (m, 2 H; ArH); 7.60-
7.42 (m, 6 H; ArH), 7.37-7.28 (m, 4 H; ArH), 7.27-7.20 (m, 2 H; ArH),
7.11-7.063 (m, 4 H; ArH), 1.37 (s, 9 H; tert-butyl CH3), 1.31 (s, 9 H; tert-
butyl CH3) (see Fig. S61). 13C NMR (75 MHz, CD2Cl2): δ (ppm) = 149.57,
149.39, 143.32, 143.23, 134.07, 134.03, 133.81, 133.71, 131.73, 131.70,
129.94, 129.64, 128.62, 128.03, 127.93, 125.52, 124.91, 39.06, 38.75,
31.15, 31.07 (see Fig. S62). 13C Dept-135 NMR (75 MHz, CD2Cl2):
Positive Signals: δ (ppm) = 134.07, 134.04, 133.81, 133.71, 131.73,
131.70, 129.94, 129.64, 128.62, 128.03, 127.94, 31.15, 31.07 (see Fig.
S63). 31P NMR (CD2Cl2): δ (ppm) = 66.58 (s, phosphine ligands) (see Fig.
a) C. Wei, C.-J. Li, J. Am. Chem. Soc. 2003, 125, 9584-9585; b) C. Wei,
Z. Li, C.-J. Li, Synlett 2004, 1472-1483; c) B. Yan, Y. Liu, Org. Lett.
2007, 9, 4323-4326; d) J. Li, L. Liu, D. Ding, J. Sun, Y. Ji, J. Dong, Org.
Lett. 2013, 15, 2884-2887; e) S. Shi, T. Wang, V. Weingand, M.
Rudolph, A. S. K. Hashmi, Angew. Chem., Int. Ed. 2014, 53, 1148-
1151; f) J. Li, M. Rudolph, F. Rominger, J. Xie, A. S. K. Hashmi, Adv.
Synth. Catal. 2016, 358, 207-211; g) A. Grirrane, E. Alvarez, H. Garcia,
A. Corma, Chem. - Eur. J. 2016, 22, 340-354; h) A. Grirrane, E. Alvarez,
H. Garcia, A. Corma, Chem. - Eur. J. 2014, 20, 14317-14328; i) A.
Grirrane, E. Alvarez, H. Garcia, A. Corma, Angew. Chem., Int. Ed. 2014,
53, 7253-7258.
[6]
a) A. S. K. Hashmi, G. J. Hutchings, Angew. Chem., Int. Ed. 2006, 45,
7896-7936; b) A. Arcadi, Chem. Rev. (Washington, DC, U. S.) 2008,
108, 3266-3325; c) S. Diez-Gonzalez, N. Marion, S. P. Nolan, Chem.
Rev. (Washington, DC, U. S.) 2009, 109, 3612-3676; d) D. J. Gorin, B.
D. Sherry, F. D. Toste, Chem. Rev. (Washington, DC, U. S.) 2008, 108,
3351-3378; e) A. Fuerstner, P. W. Davies, Angew. Chem., Int. Ed. 2007,
46, 3410-3449; f) D. Pflaesterer, A. S. K. Hashmi, Chem. Soc. Rev.
2016, 45, 1331-1367.
[7]
a) A. Grirrane, H. Garcia, A. Corma, E. Alvarez, ACS Catal. 2011, 1,
1647-1653; b) A. Grirrane, H. Garcia, A. Corma, E. Alvarez, Chem. -
Eur. J. 2013, 19, 12239-12244; c) R. E. M. Brooner, R. A. Widenhoefer,
Angew. Chem., Int. Ed. 2013, 52, 11714-11724; d) A. M. Asiri, A. S. K.
Hashmi, Chem. Soc. Rev. 2016, 45, 4471-4503.
-
S64). ESI-MS (+MS) m/z: 1117.3 amu for [C40H54Au2F6IP2Sb (31) - SbF6
]
+ (see Fig. S65). ESI-MS (-MS) m/z: 234.6 and 236.6 amu for anionic
counter ion [SbF6]- of complex 31 (see Fig. S65).
[8]
[9]
N. Mezailles, L. Ricard, F. Gagosz, Org. Lett. 2005, 7, 4133-4136.
a) A. S. K. Hashmi, E. Kurpejovic, W. Frey, J. W. Bats, Tetrahedron
2007, 63, 5879-5885; b) A. Zeiler, M. J. Ziegler, M. Rudolph, F.
Rominger, A. S. K. Hashmi, Adv. Synth. Catal. 2015, 357, 1507-1514.
Acknowledgements
[10] a) A. S. K. Hashmi, T. Lauterbach, P. Noesel, M. H. Vilhelmsen, M.
Rudolph, F. Rominger, Chem. - Eur. J. 2013, 19, 1058-1065; b) A. S. K.
Hashmi, I. Braun, P. Noesel, J. Schaedlich, M. Wieteck, M. Rudolph, F.
Rominger, Angew. Chem., Int. Ed. 2012, 51, 4456-4460; c) I. Braun, A.
M. Asiri, A. S. K. Hashmi, ACS Catal. 2013, 3, 1902-1907.
Financial support by the Spanish Ministry of Economy and
Competitiveness (Severo Ochoa and CTQ2015-69153-CO2-R1)
and Generalidad Valenciana (Prometeo 2013-014) is gratefully
acknowledged.
[11] G. A. Olah, L. Heiliger, X. Y. Li, G. K. S. Prakash, J. Am. Chem. Soc.
1990, 112, 5991-5995.
Keywords: homogeneous catalysis • organometallic chemistry •
gold complex intermediates • tremorine • gemini surfactants
[12] M. F. Espada, J. Campos, J. Lopez-Serrano, M. L. Poveda, E.
Carmona, Angew. Chem., Int. Ed. 2015, 54, 15379-15384.
[13] A. Zhdanko, M. Stroebele, M. E. Maier, Chem. - Eur. J. 2012, 18,
14732-14744, S14732/14731-S14732/14102.
[1]
a) A. K. Cho, W. L. Haslett, D. J. Jenden, Biochem. Biophys. Res.
Commun. 1961, 5, 276-279; b) F. M. Menger, J. S. Keiper, V. Azov,
[14] A. S. K. Hashmi, Angew. Chem., Int. Ed. 2010, 49, 5232-5241.
This article is protected by copyright. All rights reserved.